Verapamil Hci Injection, Solution
Product Images NDC 51662-1269

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Verapamil Hci (NDC 51662-1269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (00351662126929 Verapamil Pouch Label)

Label of Verapamil HCl Injection, USP 5 mg/2 mL (2.5 mg/mL) 2 mL vial featuring product NDC 51662-1269-2. Manufactured by HF Acquisition Co., LLC in Mukilteo, WA. The label includes lot number 12345 and expiration date 2025-01-01. It states the drug is for IV use only and sterile, nonpyrogenic. Storage instructions and a QR code are visible.*

FDA Label Image

51662-1269-3 Rfid Serialized Label (00351662126936 Verapamil Rfid Label (1))

A label displaying a Data Matrix barcode and human-readable GS1 AI-coded product identifiers including the NDC (00351662126936), expiration date (250101), lot number (12345), and serial number (43859408205). The label also notes distribution by HF Acquisition Co., LLC in Mukilteo, WA. This label corresponds to VERAPAMIL HCI Injection, Solution 2.5 mg/mL by HealthFirst.*

FDA Label Image

00351662126936 Verapamil Case Label.jpg (51662 1296 3 00351662126936 Verapamil Case Label)

Label for VERAPAMIL HCI Injection, USP 2.5 mg/mL (5 mg/2 mL) solution in a 2 mL vial, box of 25, by HF Acquisition Co LLC, DBA HealthFirst. Includes NDC 51662-1269-3, lot number, expiration date, usage and storage instructions, and manufacturer address in Mukilteo, WA. Marked for intravenous use only and RX only.*

FDA Label Image

Adverse (Adverse)

A data table titled 'Suggested Treatment of Acute Cardiovascular Adverse Reactions' summarizing adverse reactions, proven effective treatments, and supportive treatments. The table includes conditions such as symptomatic hypotension, bradycardia, AV block, asystole, and rapid ventricular rate, with associated treatments like intravenous drugs and cardiac pacing. Supportive treatments mainly include intravenous fluids and positioning.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

How Supplied (How Supplied)

A data table listing various packaging configurations and NDC codes for verapamil HCl injection, solution at a concentration of 2.5 mg/mL. It includes units of sale such as Clamcell ampuls, ANSYR plastic syringes, and Flitop vials in different quantities, with corresponding NDC numbers for each package and unit.*

FDA Label Image

Serialized Label (Serialized 51662 1269 1 Verapamil 2 1)

Verapamil HCI 5 mg/2 mL injection, solution in a clear glass vial with a gray cap. The label indicates it is a 2 mL single-dose vial distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The vial is for intravenous use as an RX only medication.*

FDA Label Image

Structure (Structure)

Chemical structure of Verapamil HCl showing its detailed molecular arrangement including aromatic rings, methoxy groups, and side chains with the hydrochloride component.*

FDA Label Image

Vial (Vial Label)

Verapamil HCI Injection, USP label for 5 mg/2 mL (2.5 mg/mL) single-dose 2 mL vial. The label includes NDC 0409-1144-65 and indicates intravenous use only. Distributed by Hospira, Inc., Lake Forest, IL, USA. Contains a barcode and instructions to protect from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.